PAR-22-032 - Drug Discovery For Nervous System Disorders (R21 Clinical Trials Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Expired NOSIs
| Title | Notice Number | Organization | Release Date | Expiration Date | Activity Code(s) |
|---|---|---|---|---|---|
| Notice of Special Interest (NOSI): AI/ML in Pre-Clinical Drug Development for Psychiatric Disorders | NOT-MH-25-050 | NIMH | Dec 20, 2024 | Sep 9, 2025 | R21, R01 |
For technical issues E-mail OER Webmaster